elements
-live
Search elements, keywords, and sectors
🔎
Elements
Subjects
Pricing
Log in
Sign up
Home
/
Subjects
/
Cystectomy
← Back to subjects
Current data, viewed at
Yearly
resolution.
Personal members see monthly resolution →
Keyword
keyword
Cystectomy
RIS
0.001
(Research Intensity Score)
Papers
57
Top papers
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines
2020 · 2159 citations
Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial
2023 · 140 citations
The 2021 Updated European Association of Urology Guidelines on Metastatic Urothelial Carcinoma
2021 · 297 citations
Final Results of Neoadjuvant Atezolizumab in Cisplatin-ineligible Patients with Muscle-invasive Urothelial Cancer of the Bladder
2022 · 199 citations
Neoadjuvant PD-L1 plus CTLA-4 blockade in patients with cisplatin-ineligible operable high-risk urothelial carcinoma
2020 · 318 citations
Neoadjuvant and adjuvant enfortumab vedotin (EV) plus pembrolizumab (pembro) for participants with muscle-invasive bladder cancer (MIBC) who are eligible for cisplatin: Randomized, open-label, phase 3 KEYNOTE-B15 study.
2026 · 12 citations
Defining cisplatin eligibility in patients with muscle-invasive bladder cancer
2021 · 147 citations
Transurethral resection of bladder tumour (TURBT)
2020 · 139 citations
Advances in the immunological microenvironment and immunotherapy of bladder cancer
2025 · 9 citations
Newest papers
Neoadjuvant and adjuvant enfortumab vedotin (EV) plus pembrolizumab (pembro) for participants with muscle-invasive bladder cancer (MIBC) who are eligible for cisplatin: Randomized, open-label, phase 3 KEYNOTE-B15 study.
2026 · 12 citations
Tumor Mutational Burden and Clinical Outcomes in Muscle-Invasive Bladder Cancer Patients Treated with Neoadjuvant Chemotherapy
2026
Urothelial carcinoma with trophoblastic differentiation: case report and review of literature
2026
Beyond surgical technique: modifiable risk factors and evolving treatment paradigms in bladder cancer surgery
2026
Conversion to Pathological Complete Response by Enfortumab Vedotin in Metastatic Sarcomatoid Urothelial Carcinoma With Nectin‐4 Expression: A Case Report
2026
Association of urinary diversion type and surgical approach with long-term renal function after radical cystectomy: a nationwide cohort study
2026
Pretreatment geriatric nutritional risk index, survival, and PD-L1 expression in muscle-invasive bladder cancer treated with neoadjuvant chemotherapy followed by radical cystectomy
2026
Cost-Effectiveness of Perioperative Durvalumab With Neoadjuvant Gemcitabine/Cisplatin in Muscle-Invasive Bladder Cancer Treatment
2026 · 1 citations
FDA Approval Summary: Durvalumab for the Treatment of Adult Patients with Muscle-Invasive Bladder Cancer
2026 · 1 citations
Browse all papers →
Cystectomy's history
Research intensity over time
Yearly
Personal members see monthly resolution →
Data temporarily unavailable — please try again shortly.
Close ✕
Cystectomy's papers
Ordered by current research-activity contribution.
Loading…
Close ✕
Read full text ↗
Share
Share on X
Share on Facebook
Share on LinkedIn
Copy link